HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 133 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $735,000 | -39.2% | 54,750 | 0.0% | 0.29% | -28.4% |
| Q2 2015 | $1,209,000 | +8.1% | 54,750 | -30.1% | 0.41% | -0.5% |
| Q1 2015 | $1,118,000 | +47.1% | 78,350 | -0.6% | 0.41% | +41.2% |
| Q4 2014 | $760,000 | -76.0% | 78,850 | -77.4% | 0.29% | -76.6% |
| Q3 2014 | $3,171,000 | -18.7% | 348,550 | -11.7% | 1.24% | -10.8% |
| Q2 2014 | $3,898,000 | -21.7% | 394,550 | +0.6% | 1.40% | -29.8% |
| Q1 2014 | $4,980,000 | +55.3% | 392,050 | +83.2% | 1.99% | +49.9% |
| Q4 2013 | $3,207,000 | +332.8% | 214,000 | +218.5% | 1.32% | +252.4% |
| Q3 2013 | $741,000 | – | 67,200 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |